2 Indian vaccines to be tested on large population

KT NEWS SERVICE. Dated: 8/4/2020 10:39:49 AM

NEW DELHI, Aug 3: The Department of Biotecnology, under the Union Science and Technology Ministry, has identified 11 centres where several thousand of healthy volunteers will be tested in the large-scale trials of two Indian vaccines against Covid-19.
The first set of institutions so selected are King Edward Memorial Medical College, Pune, Inclen Trust, Palwal (Haryana), National Institute of Epidemiology, Tirunelveli (Tamil Nadu), Christian Medical College, Vellore and Society for Health and Allied Research, Hyderabad.
They are to begin within weeks preparatory activities such as surveillance studies to decide the local population's exposure to the infections.
The second set of the institutions identified are two in Delhi and one each in Visakhapatnam, Bhubaneswar, Puducherry and Shillong.
The two home-grown vaccines, one developed by Bharat Biotech, Hyderabad and another by Zydus Cdila, Ahmedabad. The safety and efficacy of these vaccines began early last moth at multiple sites across the country.
Their trials will examine safety of the vaccines and their capacity to generate an immune response. If the trials are encouraging, the vaccines will be then assessed for their capacity to protect people from the infection through the large-scale Phase 3 trials.
The Drug Controller General of India (DCGI) on Monday announced that it has given approval to Serum Institute of India, Pune, to conduct Phase 2 and 3 clinical trials of the Oxford University's Astra Zeneca Covid-19 vaccine (COVISHIELD) in India.



Indian History... Read More



Daily horoscope